Private Biotechs Are Chasing Public Companies as IPO Window Remains Shut
Reverse mergers are emerging as a popular mechanism for private life sciences companies to reach the public markets, and that may increase if public companies continue to see their stocks stumble.
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article
Navigation 